NL-OMON53308招募中不适用
Metabolic MRI in brain cancer and epilepsy - MINT
niversitair Medisch Centrum Utrecht0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •All subjects: - Aged >18 years
- •- Ability to give informed consent
- •- Ability to follow test instructions
- •- Sufficient understanding of the Dutch or English language
- •Glioblastoma Patients in part 2a
- •- Patients who are newly diagnosed with a (suspected) glioblastoma IDH wild
- •type and with a relevant lesion (>1 cm3; prior to surgery) on conventional MRI
- •- Patients who will start treatment according to the Stupp regimen (for part 2a
- •Epilepsy Patients in part 1
- •- Patients diagnosed with epilepsy with a relevant lesion detected by FDG PET
- •Epilepsy Patients in part 2b
- •- Patients diagnosed with epilepsy with or without a lesion on conventional MRI
排除标准
- •- The presence of claustrophobia;
- •- MRI-specific exclusion criteria, such as metal implants.
- •- Refusal or inability to provide informed consent
- •- Pregnant or lactating
- •The presence of diabetes mellitus type 1 and 2;
- •The presence of a medical condition which influences brain metabolism
研究者
相似试验
招募中
不适用
7T metabolic MRI in glioma & epilepsybrain cancerepilepsy:convulsion disorderglioma: brain tumorseizure disorder1002921110039911NL-OMON55209niversitair Medisch Centrum Utrecht50
尚未招募
不适用
Monitoring of Brain Metabolites Using Proton and Deuterium MR TechniquesAgingBrain Metabolic DisorderCarotid StenosisAlzheimer DiseaseDiabetes Type 2Mild Cognitive ImpairmentBrain DiseaseNCT06705010Insel Gruppe AG, University Hospital Bern140
已完成
不适用
Analysis of glioblastoma-metabolism by MRI-SpectroscopyC71.9Brain, unspecifiedDRKS00014760Abt. Neurochirurgie UKSH Kiel44
进行中（未招募）
1 期
Metabolic MRI of amyotrophic lateral sclerosis and mini strokesEUCTR2020-000352-36-DKChristoffer Laustsen46
招募中
不适用
Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control SubjectsParkinson's DiseaseNCT04735172University Hospital, Clermont-Ferrand44